{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:10:24Z","timestamp":1774653024202,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0906-2","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T12:32:53Z","timestamp":1513859573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population"],"prefix":"10.1186","volume":"14","author":[{"given":"Pamela","family":"Moussavou-Boundzanga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isma\u00ebl Herv\u00e9","family":"Koumakpayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Labouba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Belembaogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Berthet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"906_CR1","unstructured":"Bruni L. B-RL, Albero G., Aldea M., Serrano B., Valencia S., Brotons M., Mena M., Cosano R., Munoz J., Bosch FX., de Sanjos\u00e9 S., Castellsagu\u00e9 X., ICO Information Centre on HPV and Cancer (HPV Information Centre): Human Papillomavirus and Related Diseases in the World. Summary Report 2014:12-18."},{"issue":"4","key":"906_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244\u201365.","journal-title":"J Clin Pathol"},{"issue":"1","key":"906_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"906_CR4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","volume":"12","author":"HA Katki","year":"2011","unstructured":"Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol. 2011;12(7):663\u201372.","journal-title":"Lancet Oncol"},{"issue":"5","key":"906_CR5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","volume":"119","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, et al. Overview of the European and north American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006;119(5):1095\u2013101.","journal-title":"Int J Cancer"},{"issue":"9601","key":"906_CR6","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"NW Bulkmans","year":"2007","unstructured":"Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, Voorhorst FJ, Verheijen RH, van Groningen K, Boon ME, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370(9601):1764\u201372.","journal-title":"Lancet"},{"issue":"5","key":"906_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/cyt.12083","volume":"24","author":"HA Cubie","year":"2013","unstructured":"Cubie HA, Cuschieri K. Understanding HPV tests and their appropriate applications. Cytopathology. 2013;24(5):289\u2013308.","journal-title":"Cytopathology"},{"issue":"3","key":"906_CR8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","volume":"124","author":"CJ Meijer","year":"2009","unstructured":"Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124(3):516\u201320.","journal-title":"Int J Cancer"},{"issue":"3","key":"906_CR9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijgo.2015.07.038","volume":"132","author":"N Santesso","year":"2016","unstructured":"Santesso N, Mustafa RA, Schunemann HJ, Arbyn M, Blumenthal PD, Cain J, Chirenje M, Denny L, De Vuyst H, Eckert LO, et al. World Health Organization guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016;132(3):252\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"906_CR10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13027-016-0098-1","volume":"11","author":"PB Moussavou","year":"2016","unstructured":"Moussavou PB, Koumakpayi IH, Nkili-Meyong AA, Labouba I, Bisvigou U, Chansi JK, Engohan-Aloghe C, Dissanami F, Ambounda N, Delannoy-Vieillard AS, et al. Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid\/Lugol's iodine (VIA\/VILI) in Libreville, Gabon. Infect Agent Cancer. 2016;11(1):50.","journal-title":"Infect Agent Cancer"},{"issue":"Pt 4","key":"906_CR11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","volume":"76","author":"AM de Roda Husman","year":"1995","unstructured":"de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3\u2032 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen virology. 1995;76(Pt 4):1057\u201362.","journal-title":"J Gen virology"},{"issue":"12","key":"906_CR12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","volume":"85","author":"MH Schiffman","year":"1993","unstructured":"Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"906_CR13","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1128\/JCM.37.11.3545-3555.1999","volume":"37","author":"CA Harwood","year":"1999","unstructured":"Harwood CA, Spink PJ, Surentheran T, Leigh IM, de Villiers EM, McGregor JM, Proby CM, Breuer J. Degenerate and nested PCR: a highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J Clin Microbiol. 1999;37(11):3545\u201355.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"906_CR14","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcv.2003.12.011","volume":"30","author":"TW Remmerbach","year":"2004","unstructured":"Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kuhndel K, Liebert UG. PCR detection of human papillomavirus of the mucosa: comparison between MY09\/11 and GP5+\/6+ primer sets. J Clinical Virol. 2004;30(4):302\u20138.","journal-title":"J Clinical Virol"},{"issue":"4","key":"906_CR15","first-page":"73","volume":"21","author":"BJ Kocjan","year":"2012","unstructured":"Kocjan BJ, Maver PJ, Hosnjak L, Zidar N, Odar K, Gale N, Poljak M. Comparative evaluation of the Abbott RealTime high risk HPV test and INNO-LiPA HPV genotyping extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers. Acta Dermatovenerol Alp Pannonica Adriat. 2012;21(4):73\u20135.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"906_CR16","doi-asserted-by":"crossref","unstructured":"Poljak M, Ostrbenk A, Seme K, Sterbenc A, Jancar N, Vrtacnik Bokal E. Three-year longitudinal data on the clinical performance of the Abbott RealTime high risk HPV test in a cervical cancer screening setting. J Clin Virol. 2015;","DOI":"10.1016\/j.jcv.2015.11.021"},{"issue":"Suppl 1","key":"906_CR17","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1386-6532(09)70003-4","volume":"45","author":"S Huang","year":"2009","unstructured":"Huang S, Tang N, Mak WB, Erickson B, Salituro J, Li Y, Krumpe E, Schneider G, Yu H, Robinson J, et al. Principles and analytical performance of Abbott RealTime high risk HPV test. J Clin Virol. 2009;45(Suppl 1):S13\u20137.","journal-title":"J Clin Virol"},{"issue":"5","key":"906_CR18","doi-asserted-by":"crossref","first-page":"e65226","DOI":"10.1371\/journal.pone.0065226","volume":"8","author":"SJ Salipante","year":"2013","unstructured":"Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, Jacobs MA, Miller SI, Hoogestraat DR, Cookson BT, et al. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One. 2013;8(5):e65226.","journal-title":"PLoS One"},{"issue":"10","key":"906_CR19","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","volume":"26","author":"J Shendure","year":"2008","unstructured":"Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135\u201345.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"906_CR20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cncy.21476","volume":"123","author":"MP Gailey","year":"2015","unstructured":"Gailey MP, Stence AA, Jensen CS, Ma D. Multiplatform comparison of molecular oncology tests performed on cytology specimens and formalin-fixed, paraffin-embedded tissue. Cancer Cytopathol. 2015;123(1):30\u20139.","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"906_CR21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/aje\/kwt018","volume":"178","author":"JE Tota","year":"2013","unstructured":"Tota JE, Ramanakumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS, Coutlee F, Villa LL, Franco EL. Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination. Am J Epidemiol. 2013;178(4):625\u201334.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"906_CR22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1055-9965.EPI-14-0566","volume":"24","author":"JE Tota","year":"2015","unstructured":"Tota JE, Ramanakumar AV, Villa LL, Richardson H, Burchell AN, Koushik A, Mayrand MH, Coutlee F, Franco EL. Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens. Cancer Epidemiol Biomark Prev. 2015;24(1):286\u201390.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"906_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2014.12.007","volume":"214","author":"AM Cornall","year":"2015","unstructured":"Cornall AM, Phillips S, Cummins E, Garland SM, Tabrizi SN. In vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: implications for post-vaccine surveillance studies. J Virol Methods. 2015;214:10\u20134.","journal-title":"J Virol Methods"},{"key":"906_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/1874357901206010160","volume":"6","author":"A Cid Arregui","year":"2012","unstructured":"Cid Arregui A, Gariglio P, Kanda T, Doorbar J. ONCOGENIC HUMAN PAPILLOMAVIRUSES: high-risk human Papillomaviruses: towards a better understanding of the mechanisms of viral transformation, latency and immune-escape. Open Virol J. 2012;6:160\u20132.","journal-title":"Open Virol J"},{"issue":"7","key":"906_CR25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jmv.21801","volume":"82","author":"J Cuzick","year":"2010","unstructured":"Cuzick J, Ambroisine L, Cadman L, Austin J, Ho L, Terry G, Liddle S, Dina R, McCarthy J, Buckley H, et al. Performance of the Abbott RealTime high-risk HPV test in women with abnormal cervical cytology smears. J Med Virol. 2010;82(7):1186\u201391.","journal-title":"J Med Virol"},{"issue":"Suppl 3","key":"906_CR26","first-page":"S3\/90","volume":"24","author":"J Cuzick","year":"2006","unstructured":"Cuzick J, Mayrand MH, Ronco G, Snijders P, Wardle J. Chapter 10: new dimensions in cervical cancer screening. Vaccine. 2006;24(Suppl 3):S3\/90\u20137.","journal-title":"Vaccine"},{"issue":"1","key":"906_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jviromet.2012.09.005","volume":"187","author":"J Choi","year":"2013","unstructured":"Choi J, Park Y, Lee EH, Kim S, Kim JH, Kim HS. Detection and genotyping of human papillomavirus by five assays according to cytologic results. J Virol Methods. 2013;187(1):79\u201384.","journal-title":"J Virol Methods"},{"key":"906_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jviromet.2014.04.021","volume":"205C","author":"HS Chung","year":"2014","unstructured":"Chung HS, Hahm C, Lee M. Comparison of the clinical performances of the AdvanSure HPV screening real-time PCR, the Abbott real-time high-risk HPV test, and the hybrid capture high-risk HPV DNA test for cervical cancer screening. J Virol Methods. 2014;205C:57\u201360.","journal-title":"J Virol Methods"},{"issue":"7","key":"906_CR29","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/JCM.00633-13","volume":"51","author":"AT Hesselink","year":"2013","unstructured":"Hesselink AT, Meijer CJ, Poljak M, Berkhof J, van Kemenade FJ, van der Salm ML, Bogaarts M, Snijders PJ, Heideman DA. Clinical validation of the Abbott RealTime high risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. J Clin Microbiol. 2013;51(7):2409\u201310.","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"906_CR30","first-page":"S2","volume":"4","author":"RK Gibb","year":"2011","unstructured":"Gibb RK, Martens MG. The impact of liquid-based cytology in decreasing the incidence of cervical cancer. Rev Obstet Gynecol. 2011;4(Suppl 1):S2\u2013S11.","journal-title":"Rev Obstet Gynecol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0906-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T23:32:07Z","timestamp":1719703927000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0906-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0906-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"241"}}